NCT00173888View on ClinicalTrials.gov

Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

Docetaxel, Cisplatin

docetaxel 36mg/m2 IF 30 mins on day 1,8,15 cisplatin 75mg/m2 IF 2 hrs on day 15

DRUG

Gemcitabine, Cisplatin

gemcitabine 1000mg/m2 IF 30mins on D 1,8,15, cisplatin 75mg/m2 IF 2 hrs on day 15

Trial Locations (1)

Unknown

Department of Oncology, National Taiwan University Hospital, Taipei

All Listed Sponsors

lead

National Taiwan University Hospital

OTHER

NCT00173888 - Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter